- Home
- NXDT vs TLSA Comparison
NXDT vs TLSA Comparison
Compare NXDT & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXDT
- TLSA
- Stock Information
- Founded
- NXDT 2012
- TLSA 2013
- Country
- NXDT United States
- TLSA United Kingdom
- Employees
- NXDT N/A
- TLSA N/A
- Industry
- NXDT Investment Managers
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- NXDT Finance
- TLSA Health Care
- Exchange
- NXDT Nasdaq
- TLSA Nasdaq
- Market Cap
- NXDT 192.3M
- TLSA 187.0M
- IPO Year
- NXDT N/A
- TLSA 2000
- Fundamental
- Price
- NXDT $4.87
- TLSA $1.86
- Analyst Decision
- NXDT
- TLSA
- Analyst Count
- NXDT 0
- TLSA 0
- Target Price
- NXDT N/A
- TLSA N/A
- AVG Volume (30 Days)
- NXDT 133.6K
- TLSA 225.6K
- Earning Date
- NXDT 01-01-0001
- TLSA 08-05-2025
- Dividend Yield
- NXDT 9.66%
- TLSA N/A
- EPS Growth
- NXDT N/A
- TLSA N/A
- EPS
- NXDT 0.99
- TLSA N/A
- Revenue
- NXDT N/A
- TLSA N/A
- Revenue This Year
- NXDT N/A
- TLSA N/A
- Revenue Next Year
- NXDT N/A
- TLSA N/A
- P/E Ratio
- NXDT $6.41
- TLSA N/A
- Revenue Growth
- NXDT N/A
- TLSA N/A
- 52 Week Low
- NXDT $5.89
- TLSA $0.63
- 52 Week High
- NXDT $13.07
- TLSA $1.91
- Technical
- Relative Strength Index (RSI)
- NXDT 57.33
- TLSA 70.48
- Support Level
- NXDT $4.78
- TLSA $1.62
- Resistance Level
- NXDT $5.26
- TLSA $1.89
- Average True Range (ATR)
- NXDT 0.30
- TLSA 0.10
- MACD
- NXDT 0.00
- TLSA 0.03
- Stochastic Oscillator
- NXDT 54.65
- TLSA 93.48
About NXDT NexPoint Diversified Real Estate Trust
NexPoint Diversified Real Estate Trust is a publicly traded REIT focused on opportunistic real estate investments in the United States. Their portfolio includes diverse commercial properties and investments across various real estate sectors and capital structures. The revenue sources of the company include rental income from office and retail properties, interest income from debt investments, dividend income from equity investments, and other ancillary income from tenants. The company operates through its operating partnership and wholly owned subsidiaries.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.